Kingfish portfolio manager, Fisher Funds, has reported that the company's gross performance return and adjusted net asset value return for April were better than the decline in the NZX 50 gross index.
The portfolio's gross performance return was -0.4%, while the adjusted net asset value return was -0.5%.
Fisher & Paykel Healthcare was highlighted for its strong performance, as it released a new product and continued to see growth in the US market.
However, Ryman Healthcare's chief executive, Richard Umbers, resigned, reflecting the board's desire for accelerated change and improved performance.
Shares in Fisher & Paykel Healthcare rose 11%, while shares in Ryman Healthcare declined 11%.
Kingfish is a listed investment company that invests in growing New Zealand companies.
See more
